ConductScience.org, home

Trial · NCT05704374

The Effect of Sympathetic Dysfunction on Muscle Spindle in Fibromyalgia

NCT05704374, Not applicable, Unknown, Istanbul Physical Medicine Rehabilitation Training and Research Hospital

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. The Effect of Sympathetic Dysfunction on Muscle Spindle in Fibromyalgia. Trials, record NCT05704374. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05704374

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
The Effect of Sympathetic Dysfunction on Muscle Spindle in Fibromyalgia
NCT number
NCT05704374
Status
Unknown
Phases
Not applicable
Enrollment
36 participants, estimated
Lead sponsor
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Conditions
Fibromyalgia
Interventions
sympathetic stimulation maneuver (mental arithmetic test, cold pressure test), Pregabalin 150mg
First posted
2023-01-30
Last updated
2023-05-30

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange from baseline in T-reflex amplitude after interventionimmediately after the intervention
In order to elicit the right soleus T-reflex, a constant-intensity strike will be made on the Achilles tendon with a reflex hammer at intervals of 10-15 seconds. An accelerometer will be placed over the Achilles tendon to measure T-reflex latency and confirm that strike intensities are constant. Recordings will be taken from the right soleus muscle. T-reflex peak-to-peak amplitudes will be measured in electromyographic recordings.
PrimaryChange from baseline in H-reflex amplitude after interventionimmediately after the intervention
The right tibial nerve will be stimulated with a monopolar technique from the popliteal region to elicit the soleus H-reflex response. The stimulation electrode (cathode) will be placed on the tibial nerve in the popliteal fossa and the anode will be placed on the prepatellar region. For stimulation, a 1ms monophasic square wave pulse current will be given. Mmax will be determined firstly.The current intensity providing a 10% Mmax response will be used to test the H-reflex response. H-reflex peak-to-peak amplitude will be measured in electromyographic recordings.
SecondaryHeart rate variabilityimmediately after the interventionSympathetic tone will be evaluated by measuring heart rate variability in the ECG recording taken from the DII lead.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers10

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
15542572BACKGROUNDPubMed
19101166BACKGROUNDPubMed
19411061BACKGROUNDPubMed
20147618BACKGROUNDPubMed
23838093BACKGROUNDPubMed
25994126BACKGROUNDPubMed
27026828BACKGROUNDPubMed
32120395BACKGROUNDPubMed
33119628BACKGROUNDPubMed
33454042BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Source

Release
trials-2026-11-12-0.4.0
Release manifest SHA-256
0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
Registry capture
2026-11-12
Results copy, AACT
2026-03-23
NIH clinical studies file
2026-11-13

Source ClinicalTrials.gov

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05704374

GET https://conductscience.org/api/trials/v1/NCT05704374/registered